{"id":"W4410303297","doi":"10.1080/1750743x.2025.2493039","title":"Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary","year":2025,"lang":"en","type":"article","venue":"Immunotherapy","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Medac; Cilag; Mylan; Celgene; Biogen; Gilead Sciences; Chugai Pharmaceutical; Celltrion; Sanofi; Eli Lilly and Company; AstraZeneca; Edwards Lifesciences; Amgen","keywords":"Biosimilar; Etanercept; Medicine; Plain language; Pharmacology; Internal medicine; Intensive care medicine; Oncology; Physical therapy; Rheumatoid arthritis; Linguistics","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0223269,0.0007704099,0.001943741,0.001402008,0.0004709678,0.003324081,0.0006865646,0.001802794,0.01287126],"category_scores_gemma":[0.06506791,0.0004280677,0.002345991,0.001572484,0.0004960659,0.001836147,0.0009808732,0.002333993,0.003423189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001766954,"about_ca_system_score_gemma":0.003227664,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002392235,"about_ca_topic_score_gemma":0.003734749,"domain_scores_codex":[0.975675,0.01222564,0.006782444,0.0006837709,0.00419986,0.0004333085],"domain_scores_gemma":[0.9316409,0.03620102,0.01431014,0.001436831,0.01522677,0.001184334],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"observational","study_design_scores_codex":[0.01683914,0.0008370689,0.02762489,0.05647132,0.003592049,0.000434035,0.001343454,0.0007578608,0.001549981,0.002044471,0.4703893,0.4181164],"study_design_scores_gemma":[0.0117773,0.01286022,0.1058019,0.04708631,0.005678808,0.001346831,0.00192648,0.0008754641,0.002853772,0.002993198,0.8063291,0.000470724],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"review","genre_gemma":"empirical","genre_scores_codex":[0.1115276,0.4214589,0.01427871,0.2144977,0.02312629,0.01534948,0.1303665,0.0009878137,0.06840699],"genre_scores_gemma":[0.3757866,0.2880418,0.0475872,0.1504003,0.0227259,0.02492643,0.06830609,0.0005031395,0.02172248],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.0223269,"threshold_uncertainty_score":0.1180773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02248146023747329,"score_gpt":0.3565027595321673,"score_spread":0.334021299294694,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}